FIRST TIME IN THE WORLD AND A HISTORIC MOMENT IN FIELD OF OPTHALMOLOGY
Chennai, Wednesday, 22nd November 2017: Dr. Agarwal’s Eye Hospital, India’s leading eye care chain, will soon be offering B&L’s Hypersonic Vitrectomy System, New Stellaris EliteTM Vision Enhancement System, an innovative technology for removing blood from eye using ultrasound unlike other machines which uses cutters. This latest technology is the first of its kind in the world, created on the surgical platform, which would allow surgeons to have maximum control over the surgical procedures by improving the outcomes for patients with vitreoretinal problems. The global clinical trials for this has been done by Dr.Amar Agarwal at Dr.Agarwals group of Eye Hospitals
Talking about this innovation, Dr.Amar Agarwal, Chairman, Dr. Agarwal’s Eye Hospital said, “the technology for performing vitrectomy has changed little over the last 40 years when the first single port, multi-functional pneumatic cutter was invented. With this patented technology, this would be the first & only hypersonic device for vitreous removal which is US FDA approved. It would use a novel, single needle design, a continuous open-port system and would use highly localized tissue liquefaction zone at the edge of the port to liquefy vitreous for exceptional control during tissue removal. “
The faster vitreous is cut, the less is the amount of traction on it and therefore there is decreased risk on retina. Modern vitrectomy technology today operates at speeds up to 5,000 – 7,500 cuts per minute. Vitesse would enable to increase the cutting rate to approximately 1.7 million cuts per minute with the purpose to significantly decrease the amount of vitreous traction that occurs in vitrectomy.
Mr.Sanjay Bhutani, Managing Director, Bausch & Lomb India Pvt Ltd. quoted that Vitesse hypersonic vitrectomy system, which represents the first major vitreous removal innovation in 40 years, is expected to be commercially available exclusively on Bausch + Lomb’s new Stellaris Elite™ Vision Enhancement System sometime in 2018. More details could be obtained from the Company website http://www.bausch.com/our-company/recent-news/id/2372/4262017-wednesday
The Next-Generation Stellaris Elite™ has been primarily designed for surgical platform for retinal surgery, which would provide ultimate control and efficiency during the procedure and would offer many new cutting-edge innovations and greater opportunities to add upgrades and enhancements in future. Vitesse would be able to provide a safer option to patients as it would help remove vitreous efficiently with less energy usage during retinal surgeries which would minimize the chances of injury. Faster cut rates and liquefaction of vitreous should ensure less vitreoretinal traction thereby minimizing complications such as retinal detachment, while performing procedures close to retina. Vitesse would give surgeon the options of doing vitrectomy in more complicated cases of Retina, which would be on account of its better control and efficiency.